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The nematode Caenorhabditis elegans represents one of the best model organisms for longitudinal analyses, mainly 
because of its fast life cycle and the ease of its genetic manipulation. Complex biological processes related to human 
dysfunctions developing throughout years – e.g. neurodegenerative diseases – could be investigated in C. elegans within 
a few days or even hours[1]. Because of its small size (hundreds of microns), however, high-magnification imaging is 
needed to extract relevant biological information, while microtechnology-based solutions for gentle and precise worm 
manipulation are becoming highly desirable tools in the field[2]. 
Here we present a toolkit of microfluidic solutions tailored for the automated analysis of C. elegans at each precise 
developmental stage. First, we introduce a device for on-chip nematode culture and creation of synchronized C. elegans 
embryo micro-arrays[3]. Long-term multi-dimensional imaging in this device allows systematic phenotyping studies at 
single-embryo resolution. Specifically, we demonstrate unprecedented accuracy in the analysis of embryonic 
developmental variations and successfully investigate the impact of perturbations of the mitochondrial functions on 
worm’s embryogenesis. A second device is then presented, enabling long-term automated studies on C. elegans at single-
nematode resolution and over its whole embryonic and larval development, up to adulthood. Our third device then 
features: a microfluidic design tailored for the isolation of larvae at a desired developmental stage and for their successive 
culture and treatment; a method for reversible worm immobilization, enabling long-term high-resolution imaging of adult 
worms[4]. We successfully employ this platform to analyze protein aggregation in C. elegans models for human 
neurodegenerative diseases. The device allows precisely localizing protein aggregates within the nematodes’ tissues, and 
monitoring the evolution of single aggregates over consecutive days at sub-cellular level. We believe that this toolkit will 
open new possibilities in terms of worm handling and analysis, paving the way for more accurate and efficient C. elegans 
research. 
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The vacuum bell (VB) is the only non-invasive treatment for PE, and represents a valid alternative to surgery. So far, no 
suitable tool was available for assessing objectively the efficiency of the VB. In collaboration with the University of 
Applied Sciences and Arts of Northwestern Switzerland, we developed a new measurement system, providing the 
pressure inside the VB and the related elevation of the sternum during the application of the VB. The system is mounted 
on the conventional VB, and is available for the different sizes of the VB. 67 patients were included in the study. A 
correlation between the patient’s age and the pressure related to the sternal elevation has been proven. As younger the 
patient, as lower is the pressure to lift the sternum to 1 cm. For the first time, we are enabled to gather pressure related 
elevation information in a clinical scenario. The relationship between the patient’s age, the depth of the pectus, the sternal 
elevation, and the pressure inside the VB, give an idea of the flexibility of the chest. With this information, we expect to 
 
- Predict the duration of treatment, which is supposed to be function of the age of the patient and its deformity 
 (form, length and deepest point of the PE) 
- Set up a therapeutical algorithm 
o in case of an elastic/flexible chest (low pressure): VB as first therapeutical approach 
o in case of a stiff chest (high pressure): VB to soften the chest wall in preparation of the surgery 
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Development of a pneumo-tactile vibrissae stimulator for freely behaving rodents 
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Bidirectional brain-machine interfacing requires some type of feedback loop into the subject/patient in order to establish 
a robust transmission channel. As we are currently developing such an interface, we chose to find ways to stimulate the 
somatosensory system of awake and freely roaming animals. The vibrissae-system of a rat is thought to be close enough 
to the human haptic system as to serve as a model region. Consequently, the following study reports on the development 
of a rat-portable, untethered whisker stimulating device by directed puffs of compressed air. 
At the core of the device lies a steady source of compressed air, either supplied by a custom designed peristaltic pump 
(3D printed, PLA, about 15g, pressure about 40000 Pa) controlled by an Arduino Mini Pro (Arduino LCC, Italy) or by a 
CO2 cartridge (filled with liquid CO2 12g, total weight 35g, Zefal, Germany) thread-connected to the air tube system of 
the device. CO2 cartridge fit via a custom-designed pressure reducer to a 3D printed air guide. This guiding structure with 
Arduino controlled valves (5-volt solenoid valve, 5g) is custom-fitted to a circular socket implanted onto the rodents skull 
[1] extending to adjustable, small diameter pipes (about 2mm inner diameter) running along the animal’s nose center and 
ending in back-bending arcs pointing towards the whisker aimed at. Power for the whole device is supplied by two 3-volt 
button cells connected in series (CR2025). It is currently remote controlled by a commercial IR and the device is fixed 
on a body harness for rodents. 
Bilateral air puffs are produced with a pulse width of 500 ms, with an air pressure of 40000 Pa. Frontends of working 
tubes can be exchanged to adjust for wider or narrower target regions on the rat’s whisker area. 
Experimental validation with preceding extensive habituation of animals to carry the device on the harness is under way 
and results will be presented. 
 
 
[1] Pinnell R C, Almajidy R K, Hofmann U G: Versatile 3D-Printed Headstage Implant for Group Housing of Rodents. 
Journal of Neuroscience Methods 2015. 
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Microwave evaluation of prostate tissue from transurethral resection 
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Prostate tissue obtained by transurethral resection is evaluated using two different microwave methods in the frequency 
range of 1 to 10GHz. We developed a coplanar waveguide sensor for measuring the spectral transmission and reflection 
characteristics depending on the dielectric properties of the incorporated prostate tissue. Furthermore an open ended 
coaxial probe is applied for surficial analysis of resectate tissue and complete prostate organ. The prostate tissue samples 
are measured within a few minutes after being extracted to avoid changes in the dielectric properties due to drying or 
other decomposition effects. The microwave results are compared with histologic examination results. Both measurement 
techniques are evaluated in matters of their ability to differentiate between levels of tissue degeneration (inflammation, 
neoplasia). The dielectric tissue properties in terms of the complex relative permittivity are derived by simulation 
calculations and probe calibration using reference fluids. The prospect of this work is an apparatus for fast peri-operative 
characterisation of malign and benign prostate tissue. 
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CTCelect: fully automated singularization of circulating tumor cells from 
human blood for personalized cancer immunotherapy 
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Liquid Biopsy is expected to be a future standard in cancer diagnostics and patient monitoring. Currently three groups of 
blood based biomarkers are intensively investigated to understand their prognostic value and potential for personalized 
medicine: (1) circulating tumor cells (CTCs), (2) cancer cell derived exosomes, and (3) cell-free DNA. 
CTCelect is fully automated process for enrichment, detection and isolation of single CTCs. It combines large volume 
liquid handling and an advanced microfluidic disposable in one platform. The process starts directly from 7.5 mL of 
human whole blood in a standard tube and ultimately delivers single CTCs in wells of a standard microtiter plate. 
The core steps of the fully automated process are: (1) Immunomagnetic enrichment in a pipetting station (e.g. based on 
EpCAM). (2) CTC labelling using a secondary cancer cell specific antibody. (3) Transfer of the pre-enriched suspension 
to a disposable microfluidic cartridge. (4) Detection and counting of CTCs with a miniaturized flow cytometry module. 
(4) Selective dispensing of CTCs directly into wells of a standard microtiter plate. This comprehensive process is currently 
unique in the field of automated Liquid Biopsy systems and enables downstream single cell analysis by next generation 
sequencing and/or (reverse transcriptase) quantative PCR. 
The entire process has been extensively tested with human blood spiked with 20 model cells (MCF7) and yields a cell 
recovery of 70% on a regular basis. The probability for finding one background lymphocyte per well is below 10%.  
The talk will introduce into system strategy and design, will describe new solutions found to overcome crucial 
technological hurdles, and will present experiential results gained on human blood. 
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Modular measuring systems for individual treatment and care of dementia 
patients (PYRAMID) 
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PYRAMID addresses consequently the holistic development of a miniaturized, modular, extendable measurement 
systems which allow both personnel identification, monitoring of medical parameters and a continuous interpretation of 
measured results of various functional parameters. The collection and compilation of this occurring, complex data and 
their interpretation on the basis of clinical pathways and guidelines in dealing with dementia will allow for a high level 
of acceptance for people with dementia and the caregiver. These measuring systems should not cause a foreign body 
sensation. This will minimize the risk of immediate removal of the measurement system and the actual measurement 
procedure for dementia related parameters is not perceived. Possible solutions already exist through use of measurement 
on the skin, in which the measuring system is very light and thin, and adheres to the body surface of the patient only due 
to adhesive forces. This offers to the greatest possible extent the requirement for "imperceptible" sensors. Furthermore, it 
can be placed e.g., on the patient´s back as an unobtrusive patch, making it "difficult to remove" simultaneously not 
interfering with the patient in his comfort. Possible metrics like temperature, electrophysiological data and increased 
acceleration after a fall could be detected. From the perspective of the health care personnel following challenges have 
been identified as essential: 1.Easy identification of the patient prior to evaluation of the measured values ("ID"), 2. 
Automated measurement of the most important health data, such as blood pressure, heart rate, hydration, food intake and 
excretion, sweat, blood sugar, pressure load in bedridden patients, drug delivery, etc. ("automation"), 3. Electronic data 
consolidation and evaluation of complex medical data in information system documentation ("Automatic data transfer 
and processing"), 4. Information about significant deviations of measurement data and adjustment of the existing 
knowledge (guidelines, clinical pathways) ("ICU management") 
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